Reversible pre-capillary pulmonary hypertension due to dasatinib. [electronic resource]
Producer: 20150130Description: e77-80 p. digitalISSN:- 1943-3654
- Dasatinib
- Humans
- Hypertension, Pulmonary -- chemically induced
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Phosphodiesterase 5 Inhibitors -- therapeutic use
- Piperazines -- therapeutic use
- Protein Kinase Inhibitors -- adverse effects
- Purines -- therapeutic use
- Pyrimidines -- adverse effects
- Sildenafil Citrate
- Sulfones -- therapeutic use
- Thiazoles -- adverse effects
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.